Baiya SARS-CoV-2 VAX COVID-19 vaccine

plant (Nicotiana benthamiana) produced SARS-CoV-2 receptor binding domain protein subunit vaccine

Also Known As:

Baiya SARS-CoV-2 VAX; Baiya SARS-CoV-2 VAX 1 COVID-19 vaccine; Baiya SARS-CoV-2 VAX 2 COVID-19 vaccine; Baiya SARS-CoV-2 VAX vaccine; Baiya SARS-CoV-2 VAX1 COVID-19 vaccine; Baiya SARS-CoV-2 VAX2 COVID-19 vaccine

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Subunit Vaccines: 1839
      - Baiya SARS-CoV-2 VAX COVID-19 vaccine: 2
    - Viral Vaccines: 462
      - COVID-19 Vaccines: 7607
        Baiya SARS-CoV-2 VAX COVID-19 vaccine: 2

Experts

1.	Hunsawong, Taweewun: 1 article (01/2022)
2.	Im-Erbsin, Rawiwan: 1 article (01/2022)
3.	Inthawong, Manutsanun: 1 article (01/2022)
4.	Kemthong, Taratorn: 1 article (01/2022)
5.	Khorattanakulchai, Narach: 1 article (01/2022)
6.	Klinkhamhom, Aekkarin: 1 article (01/2022)
7.	Klungthong, Chonticha: 1 article (01/2022)
8.	Malaivijitnond, Suchinda: 1 article (01/2022)
9.	Malla, Ashwini: 1 article (01/2022)
10.	Manopwisedjaroen, Suwimon: 1 article (01/2022)

Related Diseases

COVID-19

03/01/2023 - "These preliminary results demonstrate the ability of plant-produced subunit vaccine Baiya SARS-CoV-2 Vax 1 to provide protection against SARS-CoV-2 infection in hamsters."
01/01/2022 - "Overall, this work presents the results of the first systematic study of the safety profile of a plant-derived vaccine, Baiya SARS-CoV-2 Vax 1; this approach can be considered a viable strategy for the development of vaccines against COVID-19."

Related Drugs and Biologics

1.	Subunit Vaccines
2.	Vaccines